Literature DB >> 1999793

Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular administration of morphine for postoperative analgesia.

C B Berde1, B M Lehn, J D Yee, N F Sethna, D Russo.   

Abstract

A randomized, prospective trial of patient-controlled analgesia (PCA), that is, a method of analgesia administration involving a computer-driven pump activated by patients to receive small doses within defined limits was performed in 82 children and adolescents after major orthopedic surgery to compare (1) intramuscularly administered morphine, (2) PCA morphine and (3) PCA morphine with a low-dose continuous morphine infusion (PCA-plus). Patients receiving PCA and PCA-plus had lower pain scores and greater satisfaction than patients receiving intramuscularly administered morphine. The three groups used equal amounts of morphine and most measures of recovery were identical in the groups. In particular, PCA and PCA-plus did not increase the incidence of opioid-related complications, and patients receiving PCA-plus were less sedated than patients receiving intramuscular therapy. We conclude that PCA and PCA-plus are safe and effective methods of pain relief in children and adolescents after orthopedic surgery, are better accepted than intramuscular injections, and do not increase perioperative morbidity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999793     DOI: 10.1016/s0022-3476(05)82169-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  29 in total

Review 1.  Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use.

Authors:  J D Tobias
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

Review 2.  Patient-controlled analgesia: an appropriate method of pain control in children.

Authors:  A J McDonald; M G Cooper
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Postoperative pain profile in 10-15-year-olds after bilateral extraction of maxillary premolars.

Authors:  H Berlin; T List; K Ridell; T Davidson; D Toft; G Klingberg
Journal:  Eur Arch Paediatr Dent       Date:  2019-04-08

4.  The safety of concurrent administration of opioids via epidural and intravenous routes for postoperative pain in pediatric oncology patients.

Authors:  Doralina L Anghelescu; Catherine E Ross; Linda L Oakes; Laura L Burgoyne
Journal:  J Pain Symptom Manage       Date:  2008-03-04       Impact factor: 3.612

Review 5.  Pain management in children.

Authors:  L J Rice
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

Review 6.  Epidural analgesia versus intravenous patient-controlled analgesia following minimally invasive pectus excavatum repair: a systematic review and meta-analysis.

Authors:  Andrea M Stroud; Darena D Tulanont; Thomasena E Coates; Philip P Goodney; Daniel P Croitoru
Journal:  J Pediatr Surg       Date:  2014-02-22       Impact factor: 2.545

7.  Patient-controlled analgesia at the end of life at a pediatric oncology institution.

Authors:  Doralina L Anghelescu; Jennifer M Snaman; Luis Trujillo; April D Sykes; Y Yuan; Justin N Baker
Journal:  Pediatr Blood Cancer       Date:  2015-03-27       Impact factor: 3.167

8.  Is there an alternative to continuous opioid infusion for neonatal pain control? A preliminary report of parent/nurse-controlled analgesia in the neonatal intensive care unit.

Authors:  Michelle L Czarnecki; Keri Hainsworth; Pippa M Simpson; Marjorie J Arca; Michael R Uhing; Jaya Varadarajan; Steven J Weisman
Journal:  Paediatr Anaesth       Date:  2014-01-13       Impact factor: 2.556

9.  Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain.

Authors:  A Ruggiero; G Barone; L Liotti; A Chiaretti; I Lazzareschi; R Riccardi
Journal:  Support Care Cancer       Date:  2006-12-05       Impact factor: 3.603

Review 10.  Pediatric Oncology: Managing Pain at the End of Life.

Authors:  Jennifer M Snaman; Justin N Baker; Jennifer H Ehrentraut; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.